+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Consumer Health in Norway

  • ID: 2555765
  • Report
  • November 2020
  • Region: Norway
  • 121 pages
  • Euromonitor International
The outbreak of COVID-19 is not set to increase growth in 2020, with value growth of 3% predicted, compared to value growth of 4% recorded in 2019. Unlike other countries within Western Europe, there was not a high level of stockpiling reported for consumer health products in Norway. However, adult acetaminophen was one area which recorded a spike in sales in Q1 and Q2, due to the negative press surrounding ibuprofen, and adverse effects the product could have on those suffering from COVID-19.

The Consumer Health in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
EXECUTIVE SUMMARY
  • COVID-19 impact on consumer health
  • COVID-19 country impact
  • Company response
  • Retailing shift
  • What next for consumer health?
MARKET INDICATORS
  • Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
  • Table 2 Life Expectancy at Birth 2015-2020
MARKET DATA
  • Table 3 Sales of Consumer Health by Category: Value 2015-2020
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
  • Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
  • Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
  • Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
  • Table 8 Distribution of Consumer Health by Format: % Value 2015-2020
  • Table 9 Distribution of Consumer Health by Format and Category: % Value 2020
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2020-2025
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
  • Summary 1 OTC: Switches 2019-2020
GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES
  • Summary 2 Research Sources
KEY DATA FINDINGS

2020 IMPACT
  • Sales of ibuprofen decline as stories suggest the drug has adverse effects on those suffering from COVID-19, causing high levels of growth for acetaminophen
  • Diclofenac switches from OTC to Rx status, further boosting sales of adult acetaminophen in 2020
  • Paracet set to record double-digit growth, maintaining Karo Pharma AS leading position
RECOVERY AND OPPORTUNITIES
  • The forecast period will record a solid performance, as topical analgesics/anaesthetic and ibuprofen drive value growth
  • The outbreak of COVID-19, increases the interest in health, boosting sales for topical analgesics/anaesthetic
  • Prescription analgesics and a lack of innovation on the landscape are both threats to growth across the forecast period
CATEGORY DATA
  • Table 12 Sales of Analgesics by Category: Value 2015-2020
  • Table 13 Sales of Analgesics by Category: % Value Growth 2015-2020
  • Table 14 NBO Company Shares of Analgesics: % Value 2016-2020
  • Table 15 LBN Brand Shares of Analgesics: % Value 2017-2020
  • Table 16 Forecast Sales of Analgesics by Category: Value 2020-2025
  • Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Cough remedies and nasal sprays drive growth, as demand is driven up by the outbreak of COVID-19
  • Rising incidence of allergies leads to positive value growth for antihistamines/allergy remedies (systemic)
  • Otrivin from GlaxoSmithKline AS records an increase in sales, as nasal sprays sell-out in some stores, due to the outbreak of COVID-19
RECOVERY AND OPPORTUNITIES
  • Stable growth across the forecast period, driven by paediatric products as well as cough remedies
  • A rise in prescription allergy remedies is set to challenge growth for antihistamines/allergy remedies (systemic) across the forecast period
  • Nasal sprays and medicated confectionery benefit from providing instant relief, boosting sales and value growth across the forecast period
CATEGORY DATA
  • Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
  • Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
  • Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
  • Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
  • Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
  • Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • COVID-19 restrictions change consumer eating habits, negatively impacting the growth for digestive remedies
  • Proton pump inhibitors continue to drive growth, with sales rising as COVID-19 increases consumers stress levels
  • Johnson & Johnson retains its lead, as motion sickness remedies records a double-digit decline
RECOVERY AND OPPORTUNITIES
  • Stable growth across the forecast period, as consumers eat out, travel and socialise once more
  • As the outbreak of COVID-19 piques interest in health and wellness, the growing trend sees consumers focus on natural ways to improve their digestion
  • The ageing population drives growth across the forecast period, particularly benefiting antiflatulents and laxatives
CATEGORY DATA
  • Table 24 Sales of Digestive Remedies by Category: Value 2015-2020
  • Table 25 Sales of Digestive Remedies by Category: % Value Growth 2015-2020
  • Table 26 NBO Company Shares of Digestive Remedies: % Value 2016-2020
  • Table 27 LBN Brand Shares of Digestive Remedies: % Value 2017-2020
  • Table 28 Forecast Sales of Digestive Remedies by Category: Value 2020-2025
  • Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Frequent handwashing and use of home disinfectants causes skin issues for some consumers, boosting growth for dermatologicals
  • Antiparasitics/lice (head and body) treatments record a value decline as the closure of schools reduces the spread of lice
  • Well-known brands retain the trust of consumers, with a lack of private label offerings within dermatologicals
RECOVERY AND OPPORTUNITIES
  • Following a spike in growth due to COVID-19, lower levels to be recorded in 2021; however, positive growth is driven by antipruritics
  • Pollution, climate change and an ageing population will remain key growth drivers across the forecast period
  • Growing awareness of the effectiveness of antipruritics boosts demand across the forecast period, as the product drives the highest value growth
CATEGORY DATA
  • Table 30 Sales of Dermatologicals by Category: Value 2015-2020
  • Table 31 Sales of Dermatologicals by Category: % Value Growth 2015-2020
  • Table 32 NBO Company Shares of Dermatologicals: % Value 2016-2020
  • Table 33 LBN Brand Shares of Dermatologicals: % Value 2017-2020
  • Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
  • Table 35 Forecast Sales of Dermatologicals by Category: Value 2020-2025
  • Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • The Norwegian Health Institute remove smokers from the groups at risk of COVID-19; therefore, the virus has little impact on sales of NRT smoking cessation aids
  • The smoking population continues to decline as health awareness grows in the country
  • Nicorette remains the leading player, as supermarkets continue to gain share
RECOVERY AND OPPORTUNITIES
  • The COVID-19 virus will increase the interest in health and wellness, supporting steady growth across the forecast period
  • The threat of e-cigarettes may increase across the forecast period, as a loosening of regulations is under discussion
  • Other NRT will lead growth over the forecast period, as consumers invest in mouth sprays for their quick and convenient benefits
CATEGORY INDICATORS
  • Table 37 Number of Smokers by Gender 2015-2020
CATEGORY DATA
  • Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2015-2020
  • Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2015-2020
  • Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2016-2020
  • Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2017-2020
  • Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2020-2025
  • Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • COVID-19 adds to consumers stress, however, sleep aids records the same high growth levels seen in 2019
  • Women and younger people are growing audiences for sleep aids, with both groups impacted by higher levels of stress
  • Sedix retains its lead as consumers preference passion flower over valerian, while smaller players have the opportunity to breakthrough
RECOVERY AND OPPORTUNITIES
  • Growth is set to remain positive across the forecast period, with the economic recession following the outbreak of COVID-19, increasing consumers stress
  • The ongoing changes in the Rx landscape boosts sales of OTC sleep aids across the forecast period
  • Melatonin is increasingly seen as a safe alternative to OTC sleep aids, challenging growth across the forecast period
CATEGORY DATA
  • Table 44 Sales of Sleep Aids: Value 2015-2020
  • Table 45 Sales of Sleep Aids: % Value Growth 2015-2020
  • Table 46 NBO Company Shares of Sleep Aids: % Value 2016-2020
  • Table 47 LBN Brand Shares of Sleep Aids: % Value 2017-2020
  • Table 48 Forecast Sales of Sleep Aids: Value 2020-2025
  • Table 49 Forecast Sales of Sleep Aids: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Increasing use of screen time, heightened during Q1 due to the outbreak of COVID-19, impacts the demand for standard eye care
  • Allergy eye care continues to be driven by the population in Norway that suffers from pollen allergies, as the pollen count rises
  • Norwegians rely on branded eye care products, as SantenPharma AB extends its lead during 2020
RECOVERY AND OPPORTUNITIES
  • The ongoing use of digital screens, partnered with a rise in allergies, supports high levels of growth
  • The ageing population in Norway support the growth of eye care across the forecast period
  • Technological improvements in contact lenses are a challenge to growth in standard eye care
CATEGORY DATA
  • Table 50 Sales of Eye Care by Category: Value 2015-2020
  • Table 51 Sales of Eye Care by Category: % Value Growth 2015-2020
  • Table 52 NBO Company Shares of Eye Care: % Value 2016-2020
  • Table 53 LBN Brand Shares of Eye Care: % Value 2017-2020
  • Table 54 Forecast Sales of Eye Care by Category: Value 2020-2025
  • Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Sales of wound care increase, as the COVID-19 restrictions close gyms and training centres, increasing outdoor physical activity and injuries
  • The changing demographics impacts growth in wound care, as the older generation drives sales in 2020
  • Orkla Group acquires Norgesplaster AS, as Norgesplaster remains the leading offering in 2020
RECOVERY AND OPPORTUNITIES
  • As consumers go back to the gym, outdoor activities decline, however growth in wound care remains positive across the forecast period
  • The recovery time for international travel may improve sales of wound care, as an increasing amount of consumers holiday outdoors in Norway
  • The summer months and the increasing health and wellness trend are opportunities for growth across the forecast period
CATEGORY DATA
  • Table 56 Sales of Wound Care by Category: Value 2015-2020
  • Table 57 Sales of Wound Care by Category: % Value Growth 2015-2020
  • Table 58 NBO Company Shares of Wound Care: % Value 2016-2020
  • Table 59 LBN Brand Shares of Wound Care: % Value 2017-2020
  • Table 60 Forecast Sales of Wound Care by Category: Value 2020-2025
  • Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • The outbreak of COVID-19 saw consumers increase their purchases of vitamins in Q1 and Q2, reaching for products they believed would benefit the immune system
  • As well as the outbreak of COVID-19, growth in 2020 is supported by the prevalence of vitamin D deficiencies, and the increasing popularity of vitamin K2
  • Takeda AS leads the landscape with sales of Nycoplus, while e-commerce sees an increase in growth, due to the outbreak of COVID-19
RECOVERY AND OPPORTUNITIES
  • Growth will remain steady across the forecast period, with a slight increase compared to growth recorded in 2020
  • Driven by the outbreak of COVID-19, immunity-boosting ingredients drive sales across the forecast period
  • COVID-19 leads to an increase in e-commerce sales, set to improve the online landscape across the forecast period
CATEGORY DATA
  • Table 62 Sales of Vitamins by Category: Value 2015-2020
  • Table 63 Sales of Vitamins by Category: % Value Growth 2015-2020
  • Table 64 Sales of Multivitamins by Positioning: % Value 2015-2020
  • Table 65 NBO Company Shares of Vitamins: % Value 2016-2020
  • Table 66 LBN Brand Shares of Vitamins: % Value 2017-2020
  • Table 67 Forecast Sales of Vitamins by Category: Value 2020-2025
  • Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Lack of footfall in shopping centres stifles growth in 2020, as consumers stick to essential retailers during the peak of the COVID-19 crisis
  • Despite an ongoing scepticism surrounding dietary supplements, fish oils/omega fatty acids drive strong value growth and sales
  • Orkla extends its lead with Møller’s, while e-commerce continues to grow its share, as COVID-19 leads to reduced sales within specialist stores
RECOVERY AND OPPORTUNITIES
  • Dietary supplements see a rise in growth across the forecast period, as consumers return to shopping in specialist stores
  • Health and fitness trends, boosted by the outbreak of COVID-19, drive sales of mineral supplements across the forecast period
  • Sustainability is a growing concern, with manufacturers of fish oils responding accordingly, across the forecast period
CATEGORY DATA
  • Table 69 Sales of Dietary Supplements by Category: Value 2015-2020
  • Table 70 Sales of Dietary Supplements by Category: % Value Growth 2015-2020
  • Table 71 Sales of Dietary Supplements by Positioning: % Value 2015-2020
  • Table 72 NBO Company Shares of Dietary Supplements: % Value 2016-2020
  • Table 73 LBN Brand Shares of Dietary Supplements: % Value 2017-2020
  • Table 74 Forecast Sales of Dietary Supplements by Category: Value 2020-2025
  • Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • The focus on a healthy, homemade diet during the outbreak of COVID-19, leads to a decline in growth for weight management and wellbeing
  • Many Norwegians have a growing scepticism towards weight loss supplements, further impacting the decline seen in 2020
  • Nutricia Norway AS increases its lead, while direct sellers continue to have a wide share of the landscape
RECOVERY AND OPPORTUNITIES
  • Growth increases across the forecast period, as consumers reach for slimming teas and supplement nutrition drinks
  • Supplement nutrition drinks drive high value growth across the forecast period, seen as an easy and convenient solution
  • Manufacturers promote their products to align with the growing health and wellness trend, aiding sales over the forecast period
CATEGORY DATA
  • Table 76 Sales of Weight Management and Wellbeing by Category: Value 2015-2020
  • Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2015-2020
  • Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2016-2020
  • Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2017-2020
  • Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2020-2025
  • Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Closures of gyms and the reluctancy to visit shopping centres leads to a decline in growth for sports nutrition
  • Consumers adapt their workout routines, leading to less demand for sports nutrition
  • Proteinfabrikken AS maintains its lead, as e-commerce sees a further boost in share due to the outbreak of COVID-19
RECOVERY AND OPPORTUNITIES
  • Following a decline due to the COVID-19 lockdown, growth will peak in 2021 as consumers return to their previous workout regimes
  • The health and wellness trend sees consumers avoiding sugar, giving manufacturers the opportunity to adapt their offerings
  • Manufacturers are set to diversify their offerings to avoid growing maturity seen in some areas of sports nutrition
CATEGORY DATA
  • Table 82 Sales of Sports Nutrition by Category: Value 2015-2020
  • Table 83 Sales of Sports Nutrition by Category: % Value Growth 2015-2020
  • Table 84 NBO Company Shares of Sports Nutrition: % Value 2016-2020
  • Table 85 LBN Brand Shares of Sports Nutrition: % Value 2017-2020
  • Table 86 Forecast Sales of Sports Nutrition by Category: Value 2020-2025
  • Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Lack of footfall in specialist retailers leads to a decline in growth for 2020, as the COVID-19 crisis does not motivate consumers to buy herbal/traditional options
  • Sleep aids benefit from having a better reputation than prescribed alternatives, however, herbal/traditional cough and cold remedies lose sales to OTC products
  • Läkerol retains the top spot, as Sedix benefits from its passionate fruit ingredient, increasing its lead above its competitors
RECOVERY AND OPPORTUNITIES
  • Following a decline in 2020, growth peaks in 2021, before remaining steady across the rest of the forecast period
  • A reluctancy to take prescription medication, partnered with innovative offerings boost growth in herbal/traditional sleep aids across the forecast period
  • A growing focus on alternative therapy across the forecast period could boost the reputation and retail sales of herbal/traditional products
CATEGORY DATA
  • Table 88 Sales of Herbal/Traditional Products by Category: Value 2015-2020
  • Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2015-2020
  • Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2016-2020
  • Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2017-2020
  • Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2020-2025
  • Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2020-2025
KEY DATA FINDINGS

2020 IMPACT
  • Paediatric acetaminophen performs well, while negative press leads to a decline in sales for paediatric ibuprofen
  • Although Rx medications remain an ongoing threat, due to the COVID-19 virus, paediatric cough, cold and allergy remedies record double-digit value growth
  • Orkla Health AS retains its lead while Karo Pharma benefits from increased interest in paediatrics analgesics, boosting sales of Paracet
RECOVERY AND OPPORTUNITIES
  • Growth to be steady across the forecast period, albeit, lower than 2020, as demand for acetaminophen returns to normal
  • Nappy (diaper) rash treatments and paediatric cough/cold remedies benefit from children in Norway suffering from a high level of eczema and coughs and colds
  • Players compete through packaging and designs, while retailers make more space for paediatric consumer health products, boosting sales
CATEGORY DATA
  • Table 94 Sales of Paediatric Consumer Health by Category: Value 2015-2020
  • Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2015-2020
  • Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2015-2020
  • Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2016-2020
  • Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2017-2020
  • Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2020-2025
  • Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2020-2025
Note: Product cover images may vary from those shown
Adroll
adroll